MapLight Therapeutics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, MapLight Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32.31. The average 1-year stock price forecast is 169.70% higher than the current stock price, while the lowest is $20 (+66.94%) and the highest is $52 (+334.06%).

Price Target: $32.31 (+169.70%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$20	$32.31	$30	$52
Change	+66.94%	+169.70%	+150.42%	+334.06%

Analyst Ratings

The average analyst rating for MapLight Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	4	5	9	10	12	12
Buy	1	2	2	2	1	1
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	7	11	12	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ashwani Verma UBS	UBS	Hold Downgrades $52 → $13	Hold	Downgrades	$52 → $13	+8.51%	Aug 10, 2026
Unknown Analyst Jefferies No rating	Jefferies	Buy Maintains $25	Buy	Maintains	$25	+108.68%	Jul 30, 2026
Adam Vogel Craig-Hallum	Craig-Hallum	Buy Maintains $40 → $25	Buy	Maintains	$40 → $25	+108.68%	Jul 28, 2026
Evan Seigerman BMO Capital	BMO Capital	Buy Maintains $20	Buy	Maintains	$20	+66.94%	Jul 28, 2026
Sean Laaman Morgan Stanley	Morgan Stanley	Hold Downgrades $34 → $21	Hold	Downgrades	$34 → $21	+75.29%	Jul 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

20.00M

EPS This Year

-4.93

from -18.56

EPS Next Year

-3.64

from -4.93

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-
Operating Income	-31.25M	-57.28M	-82.95M	-169.08M	-252.37M
Net Income	-30.02M	-55.71M	-77.58M	-161.15M	-240.73M
EPS	-	-	-	-18.56	-4.93
Free Cash Flow	-	-32.18M	-51.86M	-83.13M	-194.00M
No. Analysts	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.98
Avg	-4.93
Low	-5.33

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-